Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3034]

Modern blood cancer treatments require new approach for monitoring, reporting side effects

Modern blood cancer treatments require new approach for monitoring, reporting side effects

UT Southwestern investigators identify missing link in kidney cancer prognosis

UT Southwestern investigators identify missing link in kidney cancer prognosis

The EU approves osimertinib for 1st-line treatment of EGFR-mutated non-small cell lung cancer

The EU approves osimertinib for 1st-line treatment of EGFR-mutated non-small cell lung cancer

Children with neuroblastoma have an elevated risk of long-term psychological difficulties

Children with neuroblastoma have an elevated risk of long-term psychological difficulties

Scientists help identify genetic markers for prostate cancer in global DNA download

Scientists help identify genetic markers for prostate cancer in global DNA download

Long periods of viral suppression shown to prevent cancer in ageing HIV population

Long periods of viral suppression shown to prevent cancer in ageing HIV population

Genome-editing tool could increase cancer risk

Genome-editing tool could increase cancer risk

FDA approves venetoclax for CLL or SLL, with or without 17 p deletion, after one prior therapy

FDA approves venetoclax for CLL or SLL, with or without 17 p deletion, after one prior therapy

ASCO 2018: First comparison of two prostate cancer therapies finds vastly different cost-effectiveness between strategies

ASCO 2018: First comparison of two prostate cancer therapies finds vastly different cost-effectiveness between...

Abiraterone not recommended by UK’s NICE as first-line treatment for advanced prostate cancer

Abiraterone not recommended by UK’s NICE as first-line treatment for advanced prostate cancer

More from ecancer